Labshake search
Citations for Stemcell Technologies :
151 - 200 of 8825 citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with the following additives: PneumacultTM Airway Organoid Seeding Supplement (Stemcell Technologies, #05062), methylcellulose (Sigma-Aldrich ...
-
bioRxiv - Bioengineering 2024Quote: ... The organoid differentiation medium (ODM) to be exchanged with was PneumacultTM Airway Organoid Basal Medium (Stemcell Technologies, #05061) supplemented with Differentiation Supplements (Stemcell Technologies ...
-
Cyborg islets: implanted flexible electronics reveal principles of human islet electrical maturationbioRxiv - Bioengineering 2024Quote: ... and then incubated in 6.5 mL DPBS and 8 mL Accutase (StemCell Technologies) for 7 min at room temperature ...
-
bioRxiv - Bioengineering 2024Quote: ... CD3+ primary human T-cells were isolated by negative selection as per manufacturer’s instructions (Cat # 15021, 15061, RosetteSep Human T-cell Enrichment Cocktail, STEMCELL Technologies, Vancouver, Canada). T-cell pellets were resuspended in dilution medium and counted using a hemocytometer with 0.4% Trypan blue viability stain (ThermoFisher Scientific ...
-
bioRxiv - Cancer Biology 2024Quote: ... 3D organoids were harvested from the basement membrane matrix using Gentle Cell Dissociation Reagent (100-0485, StemCell Technologies), fixed with 4% paraformaldehyde ...
-
bioRxiv - Cancer Biology 2024Quote: ... and heparin (10 ng/ml, Stemcell Technologies, 07980). Doubling times were computed using ...
-
bioRxiv - Cancer Biology 2024Quote: ALDH activity was measured using an Aldefluor kit (Stem Cell Technologies), according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2024Quote: ... 100ng/mL r-Noggin (Stem Cell Technologies, 78060), 5ng/mL FGF-10 (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ALDEFLUORTM Assay was performed based on the manufacturer’s protocol (Stemcell Technologies #01700). Briefly ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5ng/mL FGF-10 (Stem Cell Technologies, 78037), 37.5 ng/mL Heregulin B-1 (Peprotech ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5uM Y-27632 (Stem Cell Technologies, 72304), 50µg/mL Primocin (Invivogen ...
-
bioRxiv - Cancer Biology 2024Quote: ... 500nM SB202190 (Stem Cell Technologies, 72632), 500nM A83-01 (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... Corning 10-092-CV; 20% fetal bovine serum [FBS], Sigma-Aldrich F4135; and 0.1 mg ml-1 DNase I, Stem Cell Technologies 07900). Cell suspension was placed in a new tube ...
-
bioRxiv - Biophysics 2024Quote: ... PC-S: PneumaCult ALI-S (STEMCELL Technologies); 4 ...
-
bioRxiv - Biophysics 2024Quote: ... PC: PneumaCult ALI (STEMCELL Technologies); 3 ...
-
bioRxiv - Cell Biology 2024Quote: ... bone marrow cells were further lineage depleted using EasySep™ Mouse Hematopoietic Progenitor Cell Isolation Kit (STEMCELL Technologies).
-
bioRxiv - Cell Biology 2024Quote: ... and Heparin Solution (0.2%) (STEMCELL Technologies, 07980). CELLstart™ Humanized Substrate for Cell Culture (GIBCO ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10ng/mL epidermal growth factor (Stem Cell Technologies, 78006.1).
-
bioRxiv - Cancer Biology 2024Quote: ... 500nM A83-01 (Stem Cell Technologies, 72022), 5uM Y-27632 (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... using mTeSR Plus medium (StemCell Technologies #100-0276). mTeSR was changed every other day and cells were passaged every 3–5 days using ReLeaSR (StemCell Technologies #05872) ...
-
bioRxiv - Cancer Biology 2024Quote: ... which contained BrainPhys and SM1 (STEMCELL Technologies, Vancouver, #05792); ½ of the media was exchanged every 2–3 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... mTeSR was changed every other day and cells were passaged every 3–5 days using ReLeaSR (StemCell Technologies #05872). All cell cultures were maintained in a humidified incubator with 5% CO2 at 37°C ...
-
bioRxiv - Cell Biology 2024Quote: Plasma was isolated from extracted whole peripheral blood by adding heparin solution (STEMCELL Technologies, USA) followed by centrifugation at 1,300 g for 15 min at 4°C ...
-
bioRxiv - Cancer Biology 2024Quote: ... The frequency of LSCs was calculated using Poisson statistics with the L-Calc Software for limiting dilution analysis (StemCell Technologies)
-
bioRxiv - Cancer Biology 2024Quote: ... human and murine PBMCs underwent pre-activation through culturing in PBMCs culture medium supplemented with ImmunoCultTM Human CD3/CD28 T cell Activator (StemCell Technologies) and suspension in LymphoGrow II medium (Cytogen) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Depending on the availability100 mm3-2000 mm3 cm tumor tissue piece was minced into smaller pieces and digested with 1x Collagenase & Hyaluronidase (# 7912, Stem Cell Technologies), or 1U/mL Dispase II (# D4693 ...
-
bioRxiv - Cancer Biology 2024Quote: The EasySep™ Direct Human CTC Enrichment Kit (Catalog #19657, StemCell Technologies) along with the “Big Easy” Magnet (Catalog #18001 ...
-
bioRxiv - Cancer Biology 2024Quote: ... was dispensed to a 50 mL SepMate™ (#85450, Stemcell Technologies,) tube ...
-
bioRxiv - Cancer Biology 2024Quote: ... along with the “Big Easy” Magnet (Catalog #18001, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Cancer Biology 2024Quote: ... Red blood cells were removed from single cell suspension using ACK lysis buffer and mononuclear cells were isolated by density gradient using SepMate Tubes (StemCell Technologies) and Lymphoprep density gradient media (StemCell Technologies) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Peripheral blood mononuclear cells (PMBCs) were isolated from patient blood using Lymphoprep™ density gradient centrifugation following manufacturer protocols (STEMCELL Tech; Vancouver, Canada) and confirmed to contain ≥ 90% CD19+/CD5+ cells before use ...
-
bioRxiv - Cancer Biology 2024Quote: ... the cells were enzymatically digested using Accutase (StemCell Technologies, Vancouver, BC, Canada Cat#07920) for 15 min at 37°C ...
-
bioRxiv - Cancer Biology 2024Quote: ... gliomaspheres were enzymatically digested using Accutase (StemCell Technologies, Vancouver, BC, Canada Cat#07920) for 15 min at 37°C ...
-
bioRxiv - Cancer Biology 2024Quote: ... the cells were cultured at 37□°C in the presence of 5% CO2 in NeuroCult NS-A Proliferation solution with 10% proliferation supplement (STEMCELL Technologies, Vancouver ...
-
bioRxiv - Cancer Biology 2024Quote: ... spleen-derived B-cells were selected using the EasySep™ Mouse Pan-B Cell Isolation Kit (STEMCELL Tech).
-
bioRxiv - Cancer Biology 2024Quote: Human whole leukocytes from anonymous healthy donors were isolated from apheresis cones from ARUP using RBC sedimentation with HetaSep (STEMCELL Technologies, Vancouver, British Columbia). Freshly isolated whole leukocytes were used fresh for in vitro culture.
-
bioRxiv - Cancer Biology 2024Quote: ... and Lymphoprep density gradient media (StemCell Technologies). Subsequently ...
-
bioRxiv - Cancer Biology 2024Quote: The RosetteSep™ Human CD45 Depletion Cocktail (Catalog #15112, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Cell Biology 2024Quote: ... 25 μl accutase solution (Stemcell Technologies #07922) was added and left to incubate at room temperature for 10 min with gentle shaking ...
-
bioRxiv - Cancer Biology 2024Quote: ... in EpiCult™-B (mouse) medium supplemented with human recombinant EGF (hrEGF) (Stem Cell Technologies, 78006), human recombinant bFGF (hrbFGF ...
-
bioRxiv - Cancer Biology 2024Quote: ... and heparin (Stem Cell Technologies, 07980). 500 cells per well from LD 12:12 and CRD group tumors were added and incubated with standard cell culture conditions for 5 days in the CO2 incubator before being observed under the microscope ...
-
bioRxiv - Cancer Biology 2024Quote: ... human recombinant bFGF (hrbFGF) (Stem Cell Technologies, 78003), and heparin (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 0.1% of heparin (StemCell Technologies), and of EGF ...
-
bioRxiv - Cancer Biology 2024Quote: MDA-MB-468 and mitomycin-C treated NIH-3T3 cells were plated at a ratio of 10:1 in AggreWellTM400 plates at approximately 50 cells/microwell according to the manufacturer’s instructions (#34415, Stemcell Technologies, Vancouver, BC) and grown for 5 days in tumor media containing 1μg/mL doxycycline ...
-
bioRxiv - Cell Biology 2024Quote: ... mesoderm was carried out for 5 days and ectoderm for 7 days using STEMdiff Trilineage Differentiation Kit (STEMCELL Technologies). Alternatively ...
-
bioRxiv - Cancer Biology 2024Quote: ... single cell suspension was thawed into ImmunoCult-XF media (Stemcell Technologies) and incubated at 37°C for 1 hour ...
-
bioRxiv - Cancer Biology 2024Quote: ... in ImmunoCult-XF media (Stemcell Technologies, 10981), and expanded for 2-3 weeks until reaching the appropriate amount of T cells (usually >10 x 106 cells) ...
-
bioRxiv - Cancer Biology 2024Quote: ... cultured cells were transformed into a hypoxic chamber (Stemcell Technologies; Cat# 27310) filled with a pre-mixed gas of 2% O2 ...
-
bioRxiv - Cell Biology 2024Quote: ... and resuspended in PBS (Hyclone, SH30256.01) supplementing with 0.005% DNase I (STEMCELL Technologies, 07900) at a concentration of 1×105 cells/μl ...
-
bioRxiv - Cell Biology 2024Quote: ... iPSCs were then treated with 2 ml pre-warmed Accutase (AT104, Stem Cell Technologies) and the vessel was incubated at 37ºC for 10 mins ...